This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, ...

What you won’t see, though, are green ones. The reason for this is both a fault in the stars and in ourselves: we don’t see ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Lived experiences shape how science is conducted. This matters because who gets to speak for science steers which problems ...

The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...

Mitigating matrix effects is essential for precise XRF spectrometry. Explore methods to enhance sample consistency and ...

Among Americans, trust in science increased slightly between 2024 and 2025, according to a new Pew Research poll.

Find a portion of our conversation below, which covers Broussard’s decision to leave Humana and his thoughts on how AI could affect health care companies’ brand reputations. Editor’s Note: Transcript ...

Wikipedia had to fight to establish its legitimacy—and now it faces a new existential threat posed by generative AI ...